Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.47
-0.02 (-4.95%)
At close: May 23, 2025, 3:59 PM
0.48
0.93%
After-hours: May 23, 2025, 05:44 PM EDT

Sangamo Therapeutics Revenue

Sangamo Therapeutics reported an annual revenue of $57.8M, reflecting a -67.2% growth. For the quarter ending March 31, 2025, Sangamo Therapeutics generated $6.44M in revenue.
Revenue (ttm)
$57.8M
Revenue Growth
-67.2%
Price / Sales Ratio
3.56
Revenue / Employee
$315.85K
Employees
183
Market Cap
116.44M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.